Showing results (91-100 of 217) with videos related to
Sort By:
Pageof 22
Nucleic Acids Research|August 11, 1982
X-ray crystallographic analysis of 3-(2'-phenyl-2,4'-bithiazole-4-carboxamido) propyldimethylsulphonium iodide, an analogue of the DNA-binding portion of bleomycin A2R Kuroda, S Neidle, J M Riordan, et al.Journal of Biomolecular Structure & Dynamics|August 1, 1987
Crystallographic and molecular mechanics calculations on the anti-tumor drugs N-[(2-dimethylamino)ethyl]-and N-[(2-dimethyl-amino)butyl]-9-aminoacridine-4-carboxamides and their dications: implications for models of DNA-bindingB D Hudson, R Kuroda, W A Denny, et al.Nucleic Acids Research|April 15, 1997
Structure of a bis-amidinium derivative of hoechst 33258 complexed to dodecanucleotide d(CGCGAATTCGCG)2: the role of hydrogen bonding in minor groove drug-DNA recognitionG R Clark, D W Boykin, A Czarny, et al.Journal of Biomolecular Structure & Dynamics|December 1, 1988
Experimental DNA-binding and computer modelling studies on an analogue of the anti-tumor drug amsacrineZ H Abraham, M Agbandje, S Neidle, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Human telomerase inhibition by substituted acridine derivativesR J Harrison, S M Gowan, L R Kelland, et al.Biochemical Pharmacology|September 15, 1983
Experimental and computer graphics simulation analyses of the DNA interaction of 1,8-bis-(2-diethylaminoethylamino)-anthracene-9,10-dione, a compound modelled on doxorubicinS A Islam, S Neidle, B M Gandecha, et al.Pharmacology & Therapeutics|March 31, 2000
Structure-activity relationships among guanine-quadruplex telomerase inhibitorsS Neidle, R J Harrison, A P Reszka, et al.Biochemistry|November 24, 1992
Substituent position dictates the intercalative DNA-binding mode for anthracene-9,10-dione antitumor drugsF A Tanious, T C Jenkins, S Neidle, et al.European Journal of Biochemistry|May 1, 1993
NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2T C Jenkins, A N Lane, S Neidle, et al.Biochemical and Biophysical Research Communications|September 28, 1990
A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancerC A Laughton, S Neidle, M J Zvelebil, et al.Pageof 22